AQP4 and transverse myelitis: Second, although we only included patients whose last attack was transverse myelitis, most patients with RRMS or AQP4 + NMOSD had experienced optic neuritis or demyelinating brain attacks earlier during their disease course, which may have affected their levels of serum biomarkers.